Clinical Trial Update: Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies [Phase 3]

View source ↗

Summary

Pilot multicenter trial evaluating eculizumab for gemcitabine-induced thrombotic microangiopathy; phase 3, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Microangiopathy

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Thrombotic Microangiopathies | Phase 3 | Status: UNKNOWN